NCT01967784View on ClinicalTrials.gov

Study of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in Taiwan

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

July 31, 2014

Conditions
Influenza
Interventions
BIOLOGICAL

Quadrivalent Influenza Vaccine (split virion, inactivated)

0.5 mL, Intramuscular

Trial Locations (2)

100

Taipei

33342,

Taoyuan District

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01967784 - Study of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in Taiwan | Biotech Hunter | Biotech Hunter